U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06875609) titled 'ctDNA in Cutaneous Squamous Cell Carcinoma' on Feb. 10.
Brief Summary: The purpose of this study is to test the potential for a liquid biopsy assay to detect residual disease after surgery in patients with cutaneous squamous cell carcinoma as well as the potential for this assay to monitor response to immunotherapy treatment.
Study Start Date: April 01
Study Type: OBSERVATIONAL
Condition:
Cutaneous Squamous Cell Carcinoma
Intervention:
DIAGNOSTIC_TEST: Blood and Tissue Collection
Blood samples, and tissue samples will be collected from the participants, and used to determine whether circulating tumor DNA (ctDNA) testing can ...